Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of Tofacitinib in Vitiligo-a Randomized Controlled Trial in a Selected Tertiary Level Hospital in Dhaka

NCT05293119 is registered in ClinicalTrials.gov with Pi Research Consultancy Center, Bangladesh as lead sponsor.

NCT NCT05293119
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05293119 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of Tofacitinib in Vitiligo-a Randomized Controlled Trial in a Selected Tertiary Level Hospital in Dhaka
Lead sponsor
Pi Research Consultancy Center, Bangladesh
Phase
Phase 1
Overall status
Unknown status
Start date
May 30, 2022
Completion date
November 30, 2023
Enrollment
80 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

effect of drug, vitiligo